<bill session="116" type="h" number="3276" updated="2019-10-16T19:45:29Z">
  <state datetime="2019-06-13">REFERRED</state>
  <status>
    <introduced datetime="2019-06-13"/>
  </status>
  <introduced datetime="2019-06-13"/>
  <titles>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.</title>
    <title type="short" as="introduced">Fair AMP Act</title>
    <title type="short" as="introduced">Fair AMP Act</title>
    <title type="short" as="introduced">Fair and Accurate Medicaid Pricing Act of 2019</title>
    <title type="short" as="introduced">Fair and Accurate Medicaid Pricing Act of 2019</title>
    <title type="display">Fair AMP Act</title>
  </titles>
  <sponsor bioguide_id="K000379"/>
  <cosponsors>
    <cosponsor bioguide_id="K000378" joined="2019-06-13"/>
    <cosponsor bioguide_id="O000171" joined="2019-06-13"/>
    <cosponsor bioguide_id="S001195" joined="2019-06-13"/>
  </cosponsors>
  <actions>
    <action datetime="2019-06-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-06-13" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="4378"/>
    <bill type="s" session="116" relation="identical" number="1785"/>
    <bill type="h" session="116" relation="unknown" number="3253"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Health care costs and insurance"/>
    <term name="Health programs administration and funding"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2019-06-13T04:00:00Z" status="Introduced in House">Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act

This bill alters certain requirements and definitions under the Medicaid Drug Rebate Program relating to rebate calculations. Specifically, the bill repeals the requirement that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations.</summary>
  <committee-reports/>
</bill>
